BIIL 284 BS tablet C

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

CompletedNCT02265640

Boehringer IngelheimHealthy

Start: 2000-10-31Updated: 2014-10-16

Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS

CompletedNCT02265666

Boehringer IngelheimHealthy

Start: 2001-10-31Updated: 2014-10-16

Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

CompletedNCT02265653

Boehringer IngelheimHealthy

Start: 1999-11-30Updated: 2014-10-16